MicroRNAs (miRNAs) in neurodegenerative diseases.

The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1.

The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1.

[Anonymous].  2008.  The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1.. The Journal of neuroscience : the official journal of the Society for Neuroscience. 28(5):1213-23.

Focus on RNA isolation: obtaining RNA for microRNA (miRNA) expression profiling analyses of neural tissue.

Technical variables in high-throughput miRNA expression profiling: much work remains to be done.

Human cerebral neuropathology of Type 2 diabetes mellitus.

Differential and dynamic regulation of miR398 in response to ABA and salt stress in Populus tremula and Arabidopsis thaliana.

Anti-Argonaute RIP-Chip shows that miRNA transfections alter global patterns of mRNA recruitment to microribonucleoprotein complexes.

High-throughput experimental studies to identify miRNA targets directly, with special focus on the mammalian brain.

MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study.

Individual microRNAs (miRNAs) display distinct mRNA targeting "rules".